FDA fast tracks psychedelic drugs for mental health
Чтение
The FDA will quickly review three psychedelic drugs. These drugs may help people with mental health problems.
Two companies are studying psilocybin for depression. Another company uses a different drug for PTSD.
Special vouchers help speed up these drug reviews. The FDA wants to evaluate new treatments with urgency.
The FDA also allowed testing for a drug related to ibogaine. Research for this type of drug faced funding problems before.
Many psychedelic drugs are currently illegal to use. But now, many companies want FDA approval for them.
Вопросы
What will the FDA review?
The FDA will quickly review three psychedelic drugs.
What mental health problems are being studied?
Psilocybin is being studied for depression and another drug is being used for PTSD.
Why does the FDA want to evaluate new treatments quickly?
The FDA wants to evaluate new treatments with urgency.
Опиши изображение статьи
Посмотри на изображение статьи и опиши то, что вы видишь на нём. Можно как печатать, так и говорить голосом.
Обсуждение
Обсуди эту статью со своим ИИ-репетитором для практики. Репетитор поможет с лексикой и грамматикой.
Читайте новую статью каждый день иобсуждайте её с ИИ на lingolette.com